David Frazier is a partner in the Washington, D.C. office of Latham & Watkins and member of the Intellectual Property Litigation Practice. He devotes his practice to litigation and strategic counseling in the area of pharmaceuticals and biologics, particularly antibodies.

Dr. Frazier’s practice focuses primarily on patent litigation, strategic client counseling, due diligence analysis and providing opinions in a variety of industries including:

Biotechnology Antibody drugs Pharmaceuticals Diagnostics

Partner